Uncategorized

Intermittent Diet Comparable to Continuous Diet for T2D

A randomized noninferiority trial in Australia suggested that intermittent energy restriction is an effective alternative diet strategy for the reduction of hemoglobin A1c (HbA1c) level comparable to continuous energy restriction in patients with type 2 diabetes (T2D), and it may be superior to continuous energy restriction for weight loss. The trial included 137 participants (77 women, mean age 61.0 years, mean body mass index 36.0, and mean HbA1c level 7.3%), 97 completed the trial. Randomized interventions were an intermittent energy restriction diet (500-600 kcal/d) for 2 nonconsecutive days per week with usual diet for the other 5 days or a continuous energy restriction diet (1200-1500 kcal/d) for 7 days per week for 12 months. Intention-to-treat analysis showed similar reductions in mean HbA1c level between the continuous and intermittent energy restriction groups with a between-group difference of 0.2%, meeting the criteria for equivalence. Mean weight change was similar (–5.0 vs –6.8 kg), but the between-group difference (–1.8 kg) did not meet the criteria for equivalence, nor did the between-group difference in fat mass (–1.3 kg) or fat-free mass (–0.5 kg). There were no significant differences between groups in final step count, fasting glucose levels, lipid levels, or total medication effect score at 12 months. Effects did not differ using completers analysis. Hypoglycemic or hyperglycemic events in the first 2 weeks of treatment were similar between the groups, affecting 35% of participants (16 of 46) using sulfonylureas and/or insulin. The findings suggest that intermittent energy restriction is effective and safe for most patients with T2D who are not using glycemic agents likely to cause hypoglycemia. However, for patients using sulfonylureas and/or insulin, regular monitoring is paramount. Previous studies have shown that intermittent energy restriction is effective for weight loss comparable to continuous energy restriction. Source: https://jamanetwork.com/

hyangiu

Recent Posts

Lifestyle Intervention May Slow Early Cerebral Small-Vessel Injury

A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…

19 hours ago

Shared and Region-Specific Dementia Risk Factors

Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…

1 day ago

Comparative Benefits and Risks of Anti-Obesity Drugs

A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…

4 days ago

Early Mild Hypertrophic Cardiomyopathy May Still Carry Significant Cardiovascular Risk

Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…

6 days ago

High-Intensity Interval Exercise Reduces Energy Intake in Adults With Overweight or Obesity

A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…

7 days ago

Proton Pump Inhibitor and Antibiotic Use May Reduce the Benefit of Immunotherapy in NSCLC

Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…

1 week ago

This website uses cookies.